Remarkably, the mere activation of Wnt/ERK/CDK4/6 in E/M cells suffices to cement a programme integrating cancer stem cell maintenance (via FOXC2/p63) and self-renewal (via S-phase and FOXM1 activation) with inhibition of differentiation (via EGFR inactivation). The gene discussed is FOXC2; the disease is cancer.